News

At the Data Summit's opening keynotes, John Lewis, CKO, Explanation Age LLC, Shiva Pullepu, vice president, AI and industry solutions, CrateDB, and Sami Akbay, VP, product management, insightsoftware, ...
Squirro, a provider of enterprise-grade Generative AI (GenAI) solutions, today announced that it has been positioned as an ...
Imagine a radiologist examining a chest X-ray from a new patient. She notices the patient has swelling in the tissue but does ...
NewBiologix, a next-generation biotechnology company pioneering the future of recombinant adeno-associated virus (rAAV) production through a unique DNA-based platform built on stable cell line ...
Chainguard Libraries for Python isn't just another repository; it’s an index of Python dependencies engineered to be ...
Potential best-in-class extrahepatic in vivo gene editing with all-in-one delivery to the central nervous system (CNS) is a critical milestone for the treatment of neurological disorders - - ...
On track to begin rolling submission of Biologics License Application (BLA) for INO-3107 as a potential treatment for recurrent respiratory papillomatosis (RRP) in ...
On track to begin rolling submission of Biologics License Application (BLA) for INO-3107 as a potential treatment for recurrent respirato ...
The 9th edition of Canada’s flagship applied AI summit returns with 60 expert-led sessions, case studies, hands-on workshops, ...
Cell and gene therapies offer potential new therapeutics but are currently constrained by complex and inefficient manufacturing strategies.
Ring Therapeutics says it has demonstrated the ability to encapsidate nucleic acid payloads through in vitro assembly.